100 related articles for article (PubMed ID: 3085442)
1. [The role of aldose reductase in diabetic corneal epitheliopathy. Second report: The corneal epithelium of galactosemic rats].
Takahashi Y; Akagi Y; Akimune M; Tamura K; Itoi M
Nippon Ganka Gakkai Zasshi; 1986 Feb; 90(2):336-40. PubMed ID: 3085442
[No Abstract] [Full Text] [Related]
2. [Prevention of experimental diabetic corneal endotheliopathy with a new aldose reductase inhibitor].
Terubayashi H; Akagi Y; Takahashi Y; Ikebe H; Miyamoto Y; Ibaraki N; Yokoi N; Tutumi M; Itoi M
Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):151-5. PubMed ID: 3133928
[No Abstract] [Full Text] [Related]
3. [Prevention of experimental diabetic corneal endotheliopathy with aldose reductase inhibitor].
Akagi Y; Takahashi Y; Tanabe T; Ikebe H; Majima K; Miyatani H; Miyamoto Y; Terubayashi H
Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):187-93. PubMed ID: 3111199
[No Abstract] [Full Text] [Related]
4. Aldose reductase inhibitor (CT-112) eyedrops for diabetic corneal epitheliopathy.
Ohashi Y; Matsuda M; Hosotani H; Tano Y; Ishimoto I; Fukuda M; Manabe R
Am J Ophthalmol; 1988 Mar; 105(3):233-8. PubMed ID: 3125744
[TBL] [Abstract][Full Text] [Related]
5. Prevention or moderation of some ultrastructural changes in the RPE and retina of galactosemic rats by aldose reductase inhibition.
Vinores SA; Campochiaro PA
Exp Eye Res; 1989 Sep; 49(3):495-510. PubMed ID: 2507341
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
[No Abstract] [Full Text] [Related]
7. Inhibition of polyol pathway activity in diabetic and galactosemic rats by the aldose reductase inhibitor CP-45,634.
Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
Adv Exp Med Biol; 1979; 119():347-56. PubMed ID: 115231
[No Abstract] [Full Text] [Related]
8. [Ciliary body changes associate with aldose reductase in galactosemic rats].
Ikebe H; Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
Nippon Ganka Gakkai Zasshi; 1989 Jul; 93(7):758-62. PubMed ID: 2514592
[TBL] [Abstract][Full Text] [Related]
9. [Diabetic changes in pupillary reaction and iridal pathology. No. 1. The role of aldose reductase to the delayed pupillary reaction in galactose-fed rats].
Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
Nippon Ganka Gakkai Zasshi; 1988 Mar; 92(3):484-8. PubMed ID: 3137794
[No Abstract] [Full Text] [Related]
10. The effect of aldose reductase inhibitor, statil, on hyperpermeability of iridial vessels in experimental galactosemic rats.
Terubayashi H; Akagi Y
Jpn J Ophthalmol; 1989; 33(3):343-7. PubMed ID: 2507812
[TBL] [Abstract][Full Text] [Related]
11. Effects of aldose reductase inhibitor, CT-112, on sugar alcohol accumulation in corneal epithelium of galactose-fed rats.
Awata T; Sogo S; Yamamoto Y
Jpn J Ophthalmol; 1986; 30(3):245-50. PubMed ID: 3097363
[TBL] [Abstract][Full Text] [Related]
12. [Morphological classification of the prevention by aldose reductase inhibitor of rat galactosemic cataract].
Akagi Y; Ikebe H; Terubayashi H; Takahashi Y; Tsuji T
Nippon Ganka Gakkai Zasshi; 1989 Apr; 93(4):494-500. PubMed ID: 2508449
[TBL] [Abstract][Full Text] [Related]
13. Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors.
Lightman S; Rechthand E; Terubayashi H; Palestine A; Rapoport S; Kador P
Diabetes; 1987 Nov; 36(11):1271-5. PubMed ID: 3117606
[TBL] [Abstract][Full Text] [Related]
14. [Diabetic changes in pupillary reactions and iris histology. No. 3. The role of aldose reductase inhibitor to iridal vessel hyperpermeability of galactose-fed rats].
Kador PF; Kinoshita JH; Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
Nippon Ganka Gakkai Zasshi; 1988 Oct; 92(10):1577-81. PubMed ID: 3145680
[No Abstract] [Full Text] [Related]
15. Effects of an aldose reductase inhibitor, 1-[(p-bromophenyl)-sulfonyl]hydantoin, on cataract formation and tissue polyol levels in galactosemic rats.
Okuda J; Yashima K; Inagaki K; Miwa I
Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2990-5. PubMed ID: 3936627
[No Abstract] [Full Text] [Related]
16. [Effect of aldose reductase inhibitor (M79175) on the oscillatory potential in ERG of streptozotocin-fructose induced diabetic rats].
Funada M; Okamoto I; Fujinaga Y; Yamana T
Nippon Ganka Gakkai Zasshi; 1985 Oct; 89(10):1111-9. PubMed ID: 3938182
[No Abstract] [Full Text] [Related]
17. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
Nozawa H; Yaginuma T; Mizuno A
Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
[No Abstract] [Full Text] [Related]
18. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition.
Goldfarb S; Simmons DA; Kern EF
Trans Assoc Am Physicians; 1986; 99():67-72. PubMed ID: 3111062
[No Abstract] [Full Text] [Related]
19. [Prevention and reversal of rat galactosemic cataract with aldose reductase inhibitor--immunohistochemical study].
Akagi Y; Kador PF; Kinoshita JH; Tasaka H; Nakaji Y; Itoi M
Nippon Ganka Gakkai Zasshi; 1985 Nov; 89(11):1276-81. PubMed ID: 3937449
[No Abstract] [Full Text] [Related]
20. The effects of aldose reductase inhibitor on the corneal endothelial morphology in diabetic rats.
Matsuda M; Awata T; Ohashi Y; Inaba M; Fukuda M; Manabe R
Curr Eye Res; 1987 Feb; 6(2):391-7. PubMed ID: 2952464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
